Navigation Links
Medco Tops Fortune's Lists of 'World's Most Admired' Companies for Third Consecutive Year
Date:3/8/2010

FRANKLIN LAKES, N.J., March 8 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS), captured the No. 1 position within the Health Care: Pharmacy and Other Services sector on Fortune's World's Most Admired Companies List for the third consecutive year.  Medco ranked highest in five categories within that sector: innovation, use of corporate assets, quality of management, financial soundness, and quality of products/services.

According to the Fortune survey, Medco also received the following additional honors: No. 2 in the "Health Care: Pharmacy and Other Services" category for people management, long term investment and global competitiveness; and among the most admired companies in New Jersey.

Fortune, in partnership with the Hay Group, surveyed more than 667 companies across 55 industry sectors worldwide. To establish the rankings, executives, directors, and securities analysts were asked to rate companies in their own industry on nine criteria, from investment value to social responsibility. Results are featured in the March 22 issue of Fortune magazine.

"We are honored to be ranked the highest of our industry peers," said Medco Chairman and CEO David B. Snow, Jr. "That ranking validates our commitment to leveraging the power of advanced pharmacy to provide clinical excellence for our members and drive down total healthcare costs for our valued clients."

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately 65 million members.

With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2009 revenue of nearly $60 billion, Medco ranks 45th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.

For more information, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.

SOURCE Medco Health Solutions, Inc.

Back to top

RELATED LINKS
http://www.medcohealth.com

'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Medco Acquires Leading Genetics Healthcare Company, DNA Direct
2. Great Customer Service Just Got Better as Emedco Announces the Launch of their Completely Updated and Enhanced Website
3. N2Care Unveils Backyard Smart MEDcottage
4. Medco Health Solutions, United Drug Announce U.K. Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions; Innovations to Improve Clinical Quality, Reduce Costs
5. Gold Standard/Elsevier Launches MedCounselor Consumer Drug Information Modules
6. Medco Announces Date for Second-Quarter 2009 Financial Results
7. PATHFAST(R) Rapid Whole Blood Immunoassay Analyzer from Polymedco
8. Medcos Advanced Pharmacy Adds 162 New Jobs for Total of 1,400
9. Medco to Present at June 2009 Investor Conferences
10. Medco CEO to Present at the Sanford C. Bernstein & Co. LLC 25th Annual Strategic Decision Conference 2009
11. Medco to Present at the Deutsche Bank 34th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... 2017 , ... The non-profit Seafood Nutrition Partnership (SNP) ... the Science Symposium in partnership with the Global Organization for EPA and DHA ... a forum for global leaders in human nutrition to outline the latest consensus ...
(Date:8/22/2017)... ... August 22, 2017 , ... Western North ... at a popular international aesthetics conference for medical professionals about the positive impact ... health and his growing practice. , Dr. George K. Ibrahim shared ...
(Date:8/22/2017)... ... 22, 2017 , ... Nurses at Apple Rehab Watch Hill , a ... training and certification in Closed Pulse Irrigation™ (CPI) for wound care. This ... the Centers for Medicare and Medicaid Services, to have a CPI machine that will ...
(Date:8/22/2017)... , ... August 22, 2017 , ... ... story of child abuse and neglect, and the struggles faced while hoping for ... the creation of published author, Judy Von Bernewitz, who spent 13 years working ...
(Date:8/22/2017)... ... August 22, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5-star rating ... , As the stress of modern life continually makes more demands on time and ... artificial stimulants can trap people in vicious high/low cycles and can also cause long ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/11/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... today announced that it will release its second quarter ... conference call at 9:00am ET. The Company will discuss ... its strategy and outlook for the remainder of 2017. The ... , Chief Executive Officer, and Zvi Ben-David , ...
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
Breaking Medicine Technology: